What is Y-mAbs Therapeutics, Inc.'s contact information?

Y-mAbs Therapeutics, Inc.'s contact information: info@ymabs.com, +16468858505.

How many employees does Y-mAbs Therapeutics, Inc. have?

Y-mAbs Therapeutics, Inc. has 75 employees.

What industry does Y-mAbs Therapeutics, Inc. belong to?

Y-mAbs Therapeutics, Inc. is in the industry of: Research, Pharmaceuticals, Biotechnology, Healthcare, Biotechnology Research.

What are Y-mAbs Therapeutics, Inc.'s official social media profiles?

Y-mAbs Therapeutics, Inc. Linkedin Page

What tech stack does Y-mAbs Therapeutics, Inc. use?

Some of the popular technologies that Y-mAbs Therapeutics, Inc. uses are: Google Analytics, Cloudflare Browser Insights, WordPress, Cloudflare, Cdn.Js.

What are Y-mAbs Therapeutics, Inc.'s office addresses?

Y-mAbs Therapeutics, Inc. has 2 known office addresses: 230 Park Avenue 3350 New York, NY 10169, US Agern Alle 11 Hørsholm, Capital Region 2970, DK.

What is Y-mAbs Therapeutics, Inc.'s estimated annual revenue?

Y-mAbs Therapeutics, Inc.'s revenue is $40,000,000

What is Y-mAbs Therapeutics, Inc.'s open headcount?

Y-mAbs Therapeutics, Inc. has 9 job postings.

What is the number of ad campaigns for Y-mAbs Therapeutics, Inc.?

Y-mAbs Therapeutics, Inc. has no advertisements yet.

What is the number of recent news articles about Y-mAbs Therapeutics, Inc.?

Y-mAbs Therapeutics, Inc. has one news article.

Y-mAbs Therapeutics, Inc. - Pubrio Company Profile & Intent

Y-mAbs Therapeutics, Inc.

United States · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Healthcare

Biotechnology Research

Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets. Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.